<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. ____)*
FelCor Lodging Trust Incorporated
---------------------------------
(Name of Issuer)
Common Stock $.01 par value per share
-------------------------------------
(Title of Class of Securities)
314305 10 3
-----------
(CUSIP Number)
Lawrence D. Robinson, Esq.
Senior Vice President & General Counsel
545 E. John Carpenter Frwy., Suite 1300
Irving, Texas 75062
(972) 444-4900
---------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
July 28, 1998
-------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - Hampstead Genpar, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
- --------------------------------------------------------------------------------
<PAGE> 3
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - HH Genpar Partners
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
- --------------------------------------------------------------------------------
<PAGE> 4
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - Hampstead Associates, Inc.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 5
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - RAW Genpar, Inc.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 6
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - InMed, Inc.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 7
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - Donald J. McNamara
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE> 8
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - Robert A. Whitman
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE> 9
SCHEDULE 13D
CUSIP No. 314305 10 3 Page __ of __ Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON - Daniel A. Decker
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON -
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
OO (See Item 3)
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(D) OR 2(E) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH
REPORTING 9,630,878
PERSON -----------------------------------------------------------------
WITH 9. SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------------
10. SHARED DISPOSITIVE POWER
9,630,878
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,630,878
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.2%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE> 10
Page ____ of ____ Pages
Item 1. Security and Issuer.
The name of the issuer is FelCor Lodging Trust Incorporated
(the "Issuer"). The Issuer is organized under the laws of the State of
Maryland and its principal executive offices are located at 545 E. John
Carpenter Frwy., Suite 1300, Irving, Texas 75062. The class of equity
securities to which this statement relates are shares of the common
stock, par value $.01 per share, of the Issuer (the "Common Stock").
Item 2. Identity and Background.
(a) This statement is being filed by (i) Hampstead Genpar,
L.P., a Delaware limited partnership ("Hampstead"); (ii) HH Genpar
Partners, a Texas general partnership ("HH Genpar"); (iii) Hampstead
Associates, Inc., a Texas corporation ("Associates"); (iv) RAW Genpar,
Inc., a Texas corporation ("RAW Genpar"); (v) InMed, Inc., a Texas
corporation ("InMed"); (vi) Donald J. McNamara; (vii) Robert A.
Whitman; and (viii) Daniel A. Decker. Each of Messrs. McNamara, Whitman
and Decker is a United States citizen. Hampstead, HH Genpar,
Associates, RAW Genpar, InMed and Messrs. McNamara, Whitman and Decker
are referred to herein collectively as the "Reporting Persons." In
addition to Messrs. McNamara, Whitman and Decker, Richard M.
FitzPatrick, Philip S. Migicovsky, Kurt C. Read, Mark A. McCammon and
Kym Irvin are, or may be considered for purposes of the Securities and
Exchange Commission (the "Commission") to be, "executive officers" of
Associates (collectively, the "Other Executive Officers"). Other than
Mr. Whitman, there are no other executive officers or directors of RAW
Genpar. Other than Mr. Decker, there are no other executive officers or
directors of InMed. This statement is being filed with respect to
shares of Common Stock held of record by United/Harvey Investors I,
L.P., United/Harvey Investors II, L.P., United/Harvey Investors III,
L.P., United/Harvey Investors IV, L.P., and United/Harvey Investors V,
L.P., each a Delaware limited partnership (collectively, the
"Partnerships").
(b) The business address of each of the Reporting Persons, the
Partnerships and the Other Executive Officers is 4200 Texas Commerce
Tower West, 2200 Ross Avenue, Dallas, Texas 75201.
(c) The principal business of the Partnerships is to hold, for
investment purposes only, shares of Common Stock. The Partnerships were
formed by entities controlled by Messrs. McNamara, Whitman and Decker,
whose present principal occupation involves serving as principals in
and executive officers of a variety of affiliated
<PAGE> 11
Page ____ of ____ Pages
companies which engage in a number of investment activities, including
holding shares of Common Stock. The principal business of the other
Reporting Persons is to effectuate and implement the investment
activities of Messrs. McNamara, Whitman and Decker, including, with
respect to the Partnerships, serving as the direct and indirect general
partners of the Partnerships. The present principal occupation of the
Other Executive Officers is to serve as employees and executive
officers of various Reporting Persons and their affiliated companies.
Mr. McNamara is also a director of the Issuer.
(d) In the past five years, none of the Reporting Persons,
the Partnerships or the Other Executive Officers has been convicted in
a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) In the past five years, none of the Reporting Persons,
the Partnerships or the Other Executive Officers has been a party to a
civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
(f) The place of organization for each of the Partnerships and
Hampstead is Delaware. The place of organization for HH Genpar,
Associates, RAW Genpar and InMed is Texas. The place of citizenship of
Messrs. McNamara, Whitman and Decker and each of the Other Executive
Officers is the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
The shares of Common Stock reported on hereunder were acquired by
the respective Partnerships on July 28, 1998 pursuant to the merger
(the "Merger") of Bristol Hotel Company ("Bristol") with and into the
Issuer,
<PAGE> 12
Page ____ of ____ Pages
with the Issuer surviving such Merger. The Merger is described in
more detail in that certain Registration Statement on Form S-4 (the
"Registration Statement"), as amended, filed by the Issuer with the
Commission on June 18, 1998 (SEC File No. 333-50509). The
Registration Statement is attached hereto as Exhibit 2. In the
Merger, each shareholder of Bristol received .685 shares of Common
Stock for every share of the common stock of Bristol owned by such
shareholder at the time the Merger occurred. Bristol was, at the time
of the Merger, a reporting company under the Securities Exchange Act
of 1934, as amended, (the "Exchange Act"), and the Reporting Persons
had previously filed with the Commission on February 14, 1996 a
Schedule 13G under the Exchange Act to report their respective
ownership of shares of the common stock of Bristol. This Schedule 13D
reflects beneficial ownership of the shares of the Common Stock
acquired as a result of the consummation of the Merger.
Item 4. Purpose of Transaction.
The Reporting Persons currently hold the shares of Common Stock
reported on hereunder for investment purposes. None of the Reporting
Persons currently has any plans or proposals that relate or would
result in any of the actions set forth in parts (a) through (j) of
Item 4.
<PAGE> 13
Page ____ of ____ Pages
Item 5. Interest in Securities of the Issuer.
The Partnerships, collectively, are the record holders of the
shares of Common Stock reported on hereunder. United/Harvey Investors
I, L.P. holds 2,170,141 shares of Common Stock of record; United/Harvey
Investors II, L.P. holds 2,034,746 shares of record; United/Harvey
Investors III, L.P. holds 1,356,498 shares of record; United/Harvey
Investors IV, L.P. holds 1,356,498 shares of record; and United/Harvey
Investors V, L.P. holds 2,712,995 shares of record. None of the
Partnerships holds of record 5% or more of the issued and outstanding
Common Stock. Hampstead is the general partner of each of the
Partnerships; HH Genpar is the general partner of Hampstead;
Associates, RAW Genpar and InMed are each general partners of HH
Genpar; and Mr. McNamara is the sole shareholder and sole director of
Associates, Mr. Whitman is the sole shareholder and sole director of
RAW Genpar and Mr. Decker is the sole shareholder and sole director of
InMed. As a result of the relationships described above, each of the
Reporting Persons shares or may be deemed to share the power to vote
and dispose of all of the 9,630,878 shares of Common Stock held of
record collectively by the Partnerships and, accordingly, each may be
deemed to be a beneficial owner of all of such shares.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
At the effective time of the Merger, the Partnerships
entered into a Stockholders' and Registration Rights Agreement with
the Issuer and certain other stockholders of Bristol (the "Other
Stockholders"), which requires the Other Stockholders and the
Partnerships to vote their Common Stock and take all other necessary
action to insure that one designee of each of the Other Stockholders,
on the one hand, and the Partnerships, on the other hand, is elected to
the Issuer's Board of Directors. This obligation will terminate if
either party no longer holds at least 25% of its ownership of Common
Stock at the effective time of the Merger.
The Issuer's Articles of Amendment and Restatement
prohibits ownership by any person of more than 9.9% of the outstanding
Common Stock. This prohibition may be waived by the Issuer's Board of
Directors. The Issuer's Board of Directors waived, subject to certain
conditions, this limitation for the Partnerships and the Other
Stockholders, each of the Partnerships, on the one hand, and the Other
Stockholders, on the other hand, of which may initially own up to 15%
of the outstanding Common Stock. This percentage will be reduced to
the extent that such stockholder group fails to exercise its
preemptive rights with respect to future issuances of the Issuer's
equity securities.
The Issuer has agreed that the Partnerships will
have the preemptive right, in connection with any offering for cash in
excess of $100,000,000 of Common Stock, to purchase on the same terms
as such offering a sufficient number of shares of Common Stock to
maintain their percentage ownership of Common Stock immediately prior
to the offering. This right will expire as to the Partnerships if they
do not exercise such right with respect to three offerings or if they
no longer own at least 50% of the Common Stock owned by them at the
effective time of the Merger.
The Issuer has agreed to register the Common Stock
received by the Partnerships in the Merger with the Commission to cover
reofferings and resales of such Common Stock by the Partnerships and to
maintain such registration until such shares have been resold or may be
otherwise resold without restriction under Rules 144 and 145. The
Partnerships have agreed, however, not to sell or transfer their Common
Stock until the six-month anniversary of the effective time of the
Merger.
Item 7. Material to be Filed as Exhibits.
Exhibit 1 Powers of Attorney
Exhibit 2 Registration Statement on Form S-4 (incorporated
herein by reference to the Registration Statement
on Form S-4, as amended, filed by the Issuer with
the Commission on June 18, 1998, SEC File No.
333-50509) ("Form S-4").
Exhibit 3 Stockholders' and Registration Rights Agreement
among the Issuer, the Partnerships and the Other
Stockholders (incorporated herein by reference to
Exhibit 99.9 to the Form S-4.)
<PAGE> 14
Page ____ of ____ Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of HH Genpar Partners, Hampstead Associates, Inc., RAW
Genpar, Inc., InMed, Inc., Donald J. McNamara, Robert A. Whitman and Daniel A.
Decker.
Date: August 6, 1998 HAMPSTEAD GENPAR, L.P.
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ DANIEL A. DECKER
---------------------------
Daniel A. Decker
Executive Vice President
<PAGE> 15
Page ____ of ____ Pages
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Hampstead Genpar, L.P., Hampstead Associates, Inc.,
RAW Genpar, Inc., InMed, Inc., Donald J. McNamara, Robert A. Whitman and Daniel
A. Decker.
Date: August 6, 1998 HH GENPAR PARTNERS
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ DANIEL A. DECKER
--------------------------
Daniel A. Decker
Executive Vice President
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Hampstead Genpar, L.P., HH Genpar Partners, RAW
Genpar, Inc., InMed, Inc., Donald J. McNamara, Robert A. Whitman and Daniel A.
Decker.
Date: August 6, 1998 HAMPSTEAD ASSOCIATES, INC.
By: /s/ DANIEL A. DECKER
--------------------------
Daniel A. Decker
Executive Vice President
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Hampstead Genpar, L.P., HH Genpar Partners,
Hampstead Associates, Inc., InMed, Inc., Donald J. McNamara, Robert A. Whitman
and Daniel A. Decker.
Date: August 6, 1998 RAW GENPAR, INC.
By: /s/ ROBERT A. WHITMAN
--------------------------
Robert A. Whitman
President
<PAGE> 16
Page ____ of ____ Pages
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of it and each of Hampstead Genpar, L.P., HH Genpar Partners,
Hampstead Associates, Inc., RAW Genpar, Inc., Donald J. McNamara, Robert A.
Whitman and Daniel A. Decker.
Date: August 6, 1998 INMED, INC.
By: /s/ DANIEL A. DECKER
--------------------------
Daniel A. Decker
President
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Hampstead Genpar, L.P., HH Genpar Partners,
Hampstead Associates, Inc., RAW Genpar, Inc., InMed, Inc., Robert A. Whitman and
Daniel A. Decker.
/s/ DONALD J. MCNAMARA
Date: August 6, 1998 --------------------------
Donald J. McNamara
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Hampstead Genpar, L.P., HH Genpar Partners,
Hampstead Associates, Inc., RAW Genpar, Inc., InMed, Inc., Donald J. McNamara
and Daniel A. Decker.
/s/ ROBERT A. WHITMAN
Date: August 6, 1998 --------------------------
Robert A. Whitman
<PAGE> 17
Page ____ of ____ Pages
After reasonable inquiry and to the best of his knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct and agrees that this statement may be jointly filed
on behalf of him and each of Hampstead Genpar, L.P., HH Genpar Partners,
Hampstead Associates, Inc., RAW Genpar, Inc., InMed, Inc., Donald J. McNamara
and Robert A. Whitman.
/s/ DANIEL A. DECKER
Date: August 6, 1998 --------------------------
Daniel A. Decker
<PAGE> 18
Page ____ of ____ Pages
<TABLE>
<CAPTION>
EXHIBIT
<S> <C>
Exhibit 1 Powers of Attorney
Exhibit 2 Registration Statement on Form S-4 (incorporated
herein by reference to the Registration Statement
on Form S-4, as amended, filed by the Issuer with
the Commission on June 18, 1998, SEC File No.
333-50509) ("Form S-4").
Exhibit 3 Stockholders' and Registration Rights Agreement
among the Issuer, the Partnerships and the Other
Stockholders (incorporated herein by reference to
Exhibit 99.9 to the Form S-4.)
</TABLE>
<PAGE> 1
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
Hampstead Genpar, L.P. (the "Partnership") hereby constitutes and
appoints Mark A. Kopidlansky and Dane George, and each of them, as the
Partnership's true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, to sign on the Partnership's behalf any or all
Statements on Schedule 13D, and any or all amendments thereto, relating to the
Common Stock, par value $0.01 per share, of FelCor Lodging Trust Incorporated,
and to file the same, with all exhibits thereto, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact or agents and each of
them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the promises, hereby ratifying
and confirming all that said attorneys-in-fact or agents, or any of them or
their substitutes, may lawfully do or cause to be done by virtue hereof.
HAMPSTEAD GENPAR, L.P.
By: HH Genpar Partners
Its General Partner
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ DANIEL A. DECKER
-------------------------
Daniel A. Decker,
Executive Vice President
Dated: August 6, 1998
<PAGE> 2
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
HH Genpar Partners (the "Partnership") hereby constitutes and appoints
Mark A. Kopidlansky and Dane George, and each of them, as the Partnership's
true and lawful attorney-in-fact and agent, with full power of substitution and
resubstitution, to sign on the Partnership's behalf any or all Statements on
Schedule 13D, and any or all amendments thereto, relating to the Common Stock,
par value $0.01 per share, of FelCor Lodging Trust Incorporated, and to file the
same, with all exhibits thereto, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact or agents and each of them, full power and
authority to do and perform each and every act and thing requisite and necessary
to be done in and about the promises, hereby ratifying and confirming all that
said attorneys-in-fact or agents, or any of them or their substitutes, may
lawfully do or cause to be done by virtue hereof.
HH GENPAR PARTNERS
By: Hampstead Associates, Inc.
Its Managing General Partner
By: /s/ DANIEL A. DECKER
-------------------------
Daniel A. Decker,
Executive Vice President
Dated: August 6, 1998
<PAGE> 3
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
Hampstead Associates, Inc. (the "Company") hereby constitutes and
appoints Mark A. Kopidlansky and Dane George, and each of them, as the
Company's true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, to sign on the Company's behalf any or all
Statements on Schedule 13D, and any or all amendments thereto, relating to the
Common Stock, par value $0.01 per share, of FelCor Lodging Trust Incorporated
and to file the same, with all exhibits thereto, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact or agents and each of
them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the promises, hereby ratifying
and confirming all that said attorneys-in-fact or agents, or any of them or
their substitutes, may lawfully do or cause to be done by virtue hereof.
HAMPSTEAD ASSOCIATES, INC.
By: /s/ DANIEL A. DECKER
------------------------
Daniel A. Decker,
Executive Vice President
Dated: August 6, 1998
<PAGE> 4
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
RAW Genpar, Inc. (the "Company") hereby constitutes and appoints
Mark A. Kopidlansky, and Dane George, and each of them, as the
Company's true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, to sign on the Company's behalf any or all
Statements on Schedule 13D, and any or all amendments thereto, relating to the
Common Stock, par value $0.01 per share, of FelCor Lodging Trust Incorporated,
and to file the same, with all exhibits thereto, with the Securities and
Exchange Commission, granting unto said attorneys-in-fact or agents and each of
them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the promises, hereby ratifying
and confirming all that said attorneys-in-fact or agents, or any of them or
their substitutes, may lawfully do or cause to be done by virtue hereof.
RAW GENPAR, INC.
By: /s/ ROBERT A. WHITMAN
-----------------------
Robert A. Whitman
President
Dated: August 6, 1998
<PAGE> 5
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
InMed, Inc. (the "Company") hereby constitutes and appoints Mark A.
Kopidlansky and Dane George, and each of them, as the Company's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the Company's behalf any or all Statements on Schedule 13D, and any
or all amendments thereto, relating to the Common Stock, par value $0.01 per
share, of FelCor Lodging Trust Incorporated, and to file the same, with all
exhibits thereto, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact or agents and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in and about the promises, hereby ratifying and confirming all that said
attorneys-in-fact or agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
INMED, INC.
By: /s/ DANIEL A. DECKER
---------------------------
Daniel A. Decker,
President
Dated: August 6, 1998
<PAGE> 6
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
The undersigned hereby constitutes and appoints Mark A. Kopidlansky
and Dane George, and each of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the undersigned's behalf any or all Statements on Schedule 13D, and
any or all amendments thereto, relating to the Common Stock, par value $0.01 per
share, of FelCor Lodging Trust Incorporated, and to file the same, with all
exhibits thereto, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact or agents and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in and about the promises, hereby ratifying and confirming all that said
attorneys-in-fact or agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
/s/ DONALD J. MCNAMARA
--------------------------
Donald J. McNamara
Dated: August 6, 1998
<PAGE> 7
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
The undersigned hereby constitutes and appoints Mark A. Kopidlansky
and Dane George, and each of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the undersigned's behalf any or all Statements on Schedule 13D, and
any or all amendments thereto, relating to the Common Stock, par value $0.01 per
share, of FelCor Lodging Trust Incorporated, and to file the same, with all
exhibits thereto, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact or agents and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in and about the promises, hereby ratifying and confirming all that said
attorneys-in-fact or agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
/s/ ROBERT A. WHITMAN
-----------------------------
Robert A. Whitman
Dated: August 6, 1998
<PAGE> 8
Page ____ of ____ Pages
POWER OF ATTORNEY
Statements on Schedule 13D
The undersigned hereby constitutes and appoints Mark A. Kopidlansky
and Dane George, and each of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the undersigned's behalf any or all Statements on Schedule 13D, and
any or all amendments thereto, relating to the Common Stock, par value $0.01 per
share, of FelCor Lodging Trust Incorporated, and to file the same, with all
exhibits thereto, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact or agents and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in and about the promises, hereby ratifying and confirming all that said
attorneys-in-fact or agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
/s/ DANIEL A. DECKER
--------------------------
Daniel A. Decker
Dated: August 6, 1998
